130 related articles for article (PubMed ID: 8477178)
1. Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.
Fujimura M; Kamio Y; Matsuda T; Hashimoto T
Clin Auton Res; 1993 Feb; 3(1):31-5. PubMed ID: 8477178
[TBL] [Abstract][Full Text] [Related]
2. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
3. Oxitropium bromide. Dose-response and time-response study of a new anticholinergic bronchodilator drug.
Frith PA; Jenner B; Dangerfield R; Atkinson J; Drennan C
Chest; 1986 Feb; 89(2):249-53. PubMed ID: 3510822
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled oxitropium and fenoterol, alone and in combination, in chronic airflow obstruction.
Frith PA; Jenner B; Atkinson J
Respiration; 1986; 50 Suppl 2():294-7. PubMed ID: 3563116
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.
Nishi K; Fujimura M; Myou S; Ooka T; Sakamoto S; Saitou M; Kasahara K; Matsuda T
Clin Auton Res; 1993 Feb; 3(1):41-4. PubMed ID: 8477180
[TBL] [Abstract][Full Text] [Related]
6. Oxitropium bromide: an acute dose response study of a new anticholinergic drug in combination with fenoterol in asthma and chronic bronchitis.
Bryant DH; Rogers P
Pulm Pharmacol; 1990; 3(2):55-8. PubMed ID: 2135210
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the bronchodilating effects of oxitropium bromide and fenoterol in patients with chronic obstructive pulmonary disease.
Koyama H; Nishimura K; Ikeda A; Izumi T
Chest; 1993 Dec; 104(6):1743-7. PubMed ID: 8252955
[TBL] [Abstract][Full Text] [Related]
8. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
Cazzola M; Matera MG; Di Perna F; Calderaro F; Califano C; Vinciguerra A
Respir Med; 1998 Feb; 92(2):354-7. PubMed ID: 9616538
[TBL] [Abstract][Full Text] [Related]
9. Comparison between fenoterol and fenoterol plus oxitropium bromide delivered by metered-dose inhaler with InspirEase to relieve acute asthma attack.
Kamei T; Fujita J; Okada H; Nakamura H; Kishimoto T; Momoi A; Kawaji K; Yoshinouchi T; Ueda N; Takahara J
J Asthma; 1999; 36(1):67-75. PubMed ID: 10077137
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.
Cazzola M; Di Perna F; Centanni S; Califano C; Donner CF; D'Amato M; D'Amato G
Thorax; 1999 Dec; 54(12):1083-6. PubMed ID: 10567627
[TBL] [Abstract][Full Text] [Related]
11. Study of the bronchodilating effect of three doses of nebulized oxitropium bromide in asthmatic preschool children using the forced oscillation technique.
Pauwels JH; Desager KN; Creten WL; Van der Veken J; Van Bever HP
Eur J Pediatr; 1997 Apr; 156(4):329-32. PubMed ID: 9128822
[TBL] [Abstract][Full Text] [Related]
12. Oxitropium bromide, ipratropium bromide and fenoterol in exercise-induced asthma.
Larsson K
Respiration; 1982; 43(1):57-63. PubMed ID: 6211753
[TBL] [Abstract][Full Text] [Related]
13. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
[TBL] [Abstract][Full Text] [Related]
14. Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.
Cazzola M; Matera MG; Di Perna E; Califano C; D'Amato M; Mazzarella G
Respir Med; 1999 Dec; 93(12):909-11. PubMed ID: 10653054
[TBL] [Abstract][Full Text] [Related]
15. [Effects of inhaled beta-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with pulmonary emphysema].
Igarashi T; Nishimura M; Akiyama Y; Yamamoto M; Kobayashi S; Miyamoto K; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):32-6. PubMed ID: 8096880
[TBL] [Abstract][Full Text] [Related]
16. Early bronchodilating effect of oxitropium bromide in comparison with ipratropium bromide.
Lulling J; Delwiche JP; Prignot J
Respiration; 1981; 42(3):188-92. PubMed ID: 6458867
[TBL] [Abstract][Full Text] [Related]
17. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhaled bronchodilators on pulmonary hemodynamics at rest and during exercise in patients with COPD.
Saito S; Miyamoto K; Nishimura M; Aida A; Saito H; Tsujino I; Kawakami Y
Chest; 1999 Feb; 115(2):376-82. PubMed ID: 10027435
[TBL] [Abstract][Full Text] [Related]
20. Antitussive properties of inhaled bronchodilators on induced cough.
Lowry R; Wood A; Johnson T; Higenbottam T
Chest; 1988 Jun; 93(6):1186-9. PubMed ID: 2967164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
